Closed 19 Oct 2026 ICICI Prudential Mutual Fund · ETF · Other
ICICI Prudential Nifty Pharma ETF is a new scheme from ICICI Prudential Mutual Fund, in the ETF · Other category. Its new fund offer ran from 12 Oct 2026 to 19 Oct 2026. The minimum investment is ₹1,000. Units were offered at ₹10 each during the offer.
| Fund house | ICICI Prudential Mutual Fund |
|---|---|
| Category | ETF · Other |
| Scheme type | Open Ended |
| NFO opens | 12 Oct 2026 |
| NFO closes | 19 Oct 2026 |
| Offer price | ₹10 per unit |
| Minimum investment | 1000 |
| Exit load | Entry Load nil. Exit Load: There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon |
The objective of the investment scheme is to provide returns before expenses that closely correspond to the total return of the underlying index, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Quoted from the scheme's own document. An objective is what the scheme intends to do, not what it will achieve.
A new scheme is sold at a fixed price during its offer — here ₹10 a unit — and at its daily NAV afterwards. That fixed price is not a discount: it buys a proportionally smaller share of the same portfolio. What a new scheme genuinely lacks is a record of its own, so there is no return, no drawdown and no expense history to read yet; the objective above and the scheme information document are what exist.
Once this scheme is running you will find its NAV and performance in the Fund Explorer, and you can replay a hypothetical SIP in it with What your SIP actually did.
See all new fund offers — open, upcoming and closed.
This page lists new fund offers as AMFI publishes them, and nothing more. Aumsetu does not rate, rank, endorse or recommend any scheme or any AMC; an offer appears here because it is open, not because it is worth buying, and the order is by date alone. Every figure and every sentence about a scheme is taken from AMFI's own record — read the scheme information document before you decide anything. Aumsetu does not accept money from any AMC and cannot invest on your behalf. Mutual fund investments are subject to market risks; read all scheme related documents carefully.
